AML Insights: What’s New in the Field
Discover the key developments in the treatment of acute myeloid leukemia, including the role of menin inhibitors, MRD-guided therapy, and new combination regimens involving chidamide and FLT3-targeted agents. Several studies also address challenges in high-risk patient groups, such as those with TP53 mutations.
Don’t miss these exciting developments!
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
